HIMSS26 Turns Enterprise Imaging into the New AI Control Surface
ONE BIG THING HIMSS26 showed that imaging AI is moving from stand-alone applications toward enterprise imaging orchestration — cloud-native viewers, workflow routing, and integrated diagnostics are becoming the real control surface, while reimbursement friction and MRI operating risk remain the main constraints on scaled adoption. 🎧 Listen to this week’s Marketstrat Pulse Insight on HIMSS26: […]
Imaging AI Platformization Accelerates at ECR as OEMs Pivot to Throughput and “One-Integration” Distribution
ONE BIG THING Imaging AI is rapidly consolidating into platform procurement (bundled clinical AI + viewer/reporting + governance), while OEM differentiation is shifting toward capacity math (speed, planning automation, fewer repeats)—and reimbursement risk is re-emerging as the most levered near-term constraint for brain MRI AI. 🎧 Listen to this week’s Marketstrat Pulse Insight on ECR […]
RadNet Acquires Gleamer: The Radiology AI Platform Consolidation Thesis Takes Shape
This is an excerpt of Marketstrat’s full strategic analysis. The complete research note — including detailed competitive landscape analysis, integration risk assessment, and company profiles — is available to clients. EXECUTIVE SUMMARY On March 2, 2026, RadNet, Inc. (NASDAQ: RDNT) completed its acquisition of Gleamer SAS, a Paris-based radiology AI company, for up to €230 […]
Imaging AI Goes Infrastructure; Cloud PACS and MIS Platforms Compete for Scale
OEM-provider alliances, cloud enterprise imaging, and CPT signals accelerate distribution-led adoption across radiology and Minimally Invasive Surgery. ONE BIG THING Enterprise imaging is being purchased as infrastructure—alliances + cloud + scaled reporting networks—while MIS platforms apply the same “bundle + workflow” playbook. KEY TAKEAWAYS LATE-BREAKING UPDATE (March 2, 2026 — post-publication window) RadNet to Acquire […]
GE HealthCare + UCSF Health 10-year Care Alliance (remote scanning + workforce + clinical innovation) – Feb 27, 2026
The novelty isn’t “another partnership”—it’s the explicit positioning of imaging as an operating model problem. When alliances include remote scanning support, training pipelines, and standardized innovation workflows, the commercial unit shifts from “hardware sale” to “capacity outcomes.” That matters because in constrained labor markets, the highest-ROI “new scanner” is often the one you already own—if […]
The Marketstrat Pulse — Tariff Reset + Outcomes‑Grade AI: Imaging Economics Meets Surgical Robotics (Week Ending Feb 20, 2026)
ONE BIG THING Capacity economics is replacing algorithm novelty as imaging AI’s core battleground — validated this week by MASAI’s workload evidence, GE’s throughput-focused MRI clearances, and a tariff ruling that shifts OEM procurement conversations from cost volatility to capacity outcomes. KEY TAKEAWAYS QUICK GLANCE TABLE Date Headline Our Take Source 2026-02-20 Supreme Court limits […]
Marketstrat Releases ‘Global MRI Horizon: Market Structure, Forecasts, and AI Monetization Architecture (2024A-2035E)’ Report
New Markintel Horizon report maps the global MRI ecosystem from $15.1 billion (2024A) to $25.1 billion (2035E) and explains how AI monetization shifts. SACRAMENTO, CA, UNITED STATES — Feb. 19, 2026 — Marketstrat today announced the release of its latest Markintel™ Horizon report, “Global MRI Horizon: Market Structure, Forecasts, and AI Monetization Architecture (2024A–2035E)” (Report […]
The Marketstrat Pulse — Clearances, Channels, and Coverage Risk: Imaging AI Becomes Enterprise Infrastructure (Feb 13, 2026)
ONE BIG THING Imaging AI’s scaling constraint is shifting from model performance to “get paid + get distributed,” as Median’s end‑to‑end lung cancer screening clearance and Tempus Pixel distribution move collide with a fragile CMS OPPS payment construct that can swing AI software reimbursement by ~9× based on claims data. KEY TAKEAWAYS INNOVATION HOOK The […]
GE HealthCare: Procedure-Room AI Platformization Accelerates
Date: February 11, 2026 | Company: GE Healthcare (GEHC) | Sector Lens: Interventional Imaging + Workflow AI | Cath Lab Economics | Platform Procurement GE HealthCare’s Allia Moveo FDA clearance/CE Mark is a signal that AI is embedding directly into interventional imaging workflows. The same-week Medtronic–CathWorks deal highlights a parallel consolidation of angiography-derived decision support, […]
The Marketstrat Pulse — ROI Telemetry Becomes the Moat: Imaging AI Shifts From ‘Accuracy’ to Measurable Capacity + Revenue (Feb 6, 2026)
ONE BIG THING Imaging AI crossed a commercial Rubicon this week: reimbursement tightened (NGS draft noncoverage for brain MRI AI quantification) while “ROI telemetry” emerged as the winning sales language—AI is increasingly bought as measurable capacity-and-revenue infrastructure, not a standalone accuracy feature. KEY TAKEAWAYS MARKETSTRAT POV (ACTIONABLE STRATEGY) INNOVATION HOOK ROI telemetry becomes the moat”: […]
